142 related articles for article (PubMed ID: 9416483)
1. bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer.
Parenti AR; Rugge M; Shiao YH; Ruol A; Ancona E; Bozzola L; Ninfo V
Histopathology; 1997 Nov; 31(5):430-5. PubMed ID: 9416483
[TBL] [Abstract][Full Text] [Related]
2. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa.
Mandard AM; Marnay J; Lebeau C; Benard S; Mandard JC
J Pathol; 1997 Feb; 181(2):153-7. PubMed ID: 9120718
[TBL] [Abstract][Full Text] [Related]
6. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
7. Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Fukuda K; Oka S; Hisamitsu K; Yamaguchi K; Tsujitani S; Kaibara N
J Clin Pathol; 2002 Feb; 55(2):121-6. PubMed ID: 11865007
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Patel YV; Shah NG; Ghosh N; Suthar TP; Balar DB
J Surg Oncol; 1997 Jun; 65(2):111-6. PubMed ID: 9209522
[TBL] [Abstract][Full Text] [Related]
10. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Sarbia M; Bittinger F; Grabellus F; Verreet P; Dutkowski P; Willers R; Gabbert HE
Int J Cancer; 1997 Nov; 73(4):508-13. PubMed ID: 9389564
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus.
Puglisi F; Di Loreto C; Panizzo R; Avellini C; Fongione S; Cacitti V; Beltrami CA
J Clin Pathol; 1996 Jun; 49(6):456-9. PubMed ID: 8763257
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
[TBL] [Abstract][Full Text] [Related]
15. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation.
Cho KJ; Jang JJ; Lee SS; Zo JI
Histopathology; 2000 Apr; 36(4):331-40. PubMed ID: 10759947
[TBL] [Abstract][Full Text] [Related]
16. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
17. p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.
Yasuda M; Kuwano H; Watanabe M; Toh Y; Ohno S; Sugimachi K
Br J Cancer; 2000 Oct; 83(8):1033-8. PubMed ID: 10993651
[TBL] [Abstract][Full Text] [Related]
18. bcl-2, p53 immunophenotypes and apoptosis in squamous cell carcinoma of the oesophagus.
Sur M; Cooper K
Histopathology; 1998 Jul; 33(1):87-8. PubMed ID: 9726057
[No Abstract] [Full Text] [Related]
19. [The protein expression of p53 and bcl-2 in laryngeal squamous cell carcinoma].
Liu S; Tang S; Lin Y; Liang C
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):191-3. PubMed ID: 12600081
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
